Recombinant human brain natriuretic peptide (Suzhou Landing Bioteh)

重组人脑钠素(苏州兰鼎生物制药)

Report date: 2026/03/26 20:00:17

Base Information

Drug NameRecombinant human brain natriuretic peptide (Suzhou Landing Bioteh)
Drug Alias Name重组人脑利钠肽
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNatriuretic peptide receptor 1 agonists
TargetsNatriuretic peptide receptor 1
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsHeart Failure
Approved Indications in ChinaHeart Failure
Original Approved Country/TerritoryMainland China
Original Approved Date2025/04/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A